Proteins found in the microtubules.
An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.
Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.
A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.
A characteristic symptom complex.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.
Genetic diseases that are linked to gene mutations on the X CHROMOSOME in humans (X CHROMOSOME, HUMAN) or the X CHROMOSOME in other species. Included here are animal models of human X-linked diseases.
'Abnormalities, Multiple' is a broad term referring to the presence of two or more structural or functional anomalies in an individual, which may be genetic or environmental in origin, and can affect various systems and organs of the body.
A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.
A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant.
Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
A disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.

Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome. (1/122)

7-Dehydrocholesterol accumulates in fetuses affected by the Smith-Lemli-Opitz syndrome as a result of a deficit in the ultimate step of cholesterol synthesis catalyzed by Delta7 reductase. Rat embryos explanted at gestation day 10 and cultured for 48 h in the presence of the Delta7 reductase inhibitor AY 9944 were used as a model to discriminate between the beneficial effect of supplementation with cholesterol and the deleterious effect of supplementation with 7-dehydrocholesterol. Cholesterol supplementation in the form of mixed cholesterol/lecithin liposomes added to serum serving as the culture medium restores the growth of embryos which is markedly decreased in the presence of the inhibitor. 7-Dehydrocholesterol under identical conditions does not restore growth and impairs the beneficial effect of cholesterol added simultaneously. UV-photooxidation of 7-dehydrocholesterol-supplemented culture medium enhances its embryotoxicity, which suggests uptake by the embryo of toxic by-products formed from 7-dehydrocholesterol. By contrast photooxidation of cholesterol-supplemented culture medium does not induce embryotoxicity. alpha-Tocopherol reduces the toxicity of photooxidized 7-dehydrocholesterol supplementing the culture medium. We conclude that 7-dehydrocholesterol does not fulfill the cholesterol requirement of the developing embryos and exerts an additional embryotoxic effect probably via oxidized by-products. This could explain the antenatal growth retardation of SLOS by a blockage of the maternal compensatory cholesterol influx.  (+info)

The Opitz syndrome gene product, MID1, associates with microtubules. (2/122)

Opitz syndrome (OS) is a genetically heterogeneous disorder characterized by defects of the ventral midline, including hypertelorism, cleft lip and palate, heart defects, and mental retardation. We recently identified the gene responsible for X-linked OS. The ubiquitously expressed gene product, MID1, is a member of the RING finger family. These proteins are characterized by an N-terminal tripartite protein-protein interaction domain and a conserved C terminus of unknown function. Unlike other RING finger proteins for which diverse cellular functions have been proposed, the function of MID1 is as yet undefined. By using the green fluorescent protein as a tag, we show here that MID1 is a microtubule-associated protein that influences microtubule dynamics in MID1-overexpressing cells. We confirm this observation by demonstrating a colocalization of MID1 and tubulin in subcellular fractions and the association of endogenous MID1 with microtubules after in vitro assembly. Furthermore, overexpressed MID1 proteins harboring mutations described in OS patients lack the capability to associate with microtubules, forming cytoplasmic clumps instead. These data give an idea of the possible molecular pathomechanism underlying the OS phenotype.  (+info)

Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein. (3/122)

The cDNA encoding the 471-amino acid rat 7-dehydrocholesterol reductase (DHCR), an enzyme that has been implicated in both cholesterol biosynthesis and developmental abnormalities (e.g. Smith-Lemli-Opitz syndrome) in mammals, has been cloned and sequenced, and the primary structure of the enzyme has been deduced. The DHCR gene was mapped to chromosome 8q2.1 by fluorescence in situ hybridization. Rat DHCR, calculated molecular mass of 54.15-kDa polypeptide, shares a close amino acid identity with mouse and human DHCRs (96 and 87%, respectively) as compared with its other related proteins (e.g. fungal sterol Delta14-reductase) and exhibits high hydrophobicity (>68%) with 9 transmembrane domains. Five putative sterol-sensing domains were predicted to be localized in transmembrane domains 4-8, which are highly homologous to those found in 3-hydroxymethylglutaryl-CoA reductase, sterol regulatory element-binding protein cleavage-activating protein, and patched protein. The polypeptide encoded by DHCR cDNA was expressed in yeast as a 55.45-kDa myc-tagged fusion protein, which was recognized with anti-myc monoclonal antibody 9E10 and shown to possess full DHCR activity with respect to dependence on NADPH and sensitivity to DHCR inhibitors. Northern blot analysis indicates that the highest expression of DHCR mRNA was detected in liver, followed by kidney and brain. In rat brains, the highest level of mRNA encoding DHCR was detected in the midbrain, followed by the spinal cord and medulla. Feeding rats 5% cholestyramine plus 0.1% lovastatin in chow resulted in both approximately a 3-fold induction of DHCR mRNA and a 5-fold increase of the enzymic activity in the liver. When rats were fed 0.1% (w/w) AY-9944 (in chow) for 14-days, a complete inhibition of DHCR activity and a significant reduction in serum total cholesterol level were observed. However, the level of hepatic DHCR mRNA fell only slightly, suggesting that AY-9944 may act more rapidly at the protein level than at the level of transcription of the DHCR gene under these conditions.  (+info)

Marked alteration of sterol metabolism and composition without compromising retinal development or function. (4/122)

PURPOSE: To evaluate the consequences of altering retinal sterol metabolism and composition on the development, histologic organization, and electrophysiological function of the retina, under conditions that mimic the biochemical hallmarks of the Smith-Lemli-Opitz (SLO) syndrome. METHODS: Pregnant Sprague-Dawley rats were fed cholesterol-free chow containing AY9944 (treated group), an inhibitor of 3beta-hydroxysterol delta7-reductase, from gestational day 6 through postnatal day (P)28. Control animals were fed the same chow, but without AY9944. In addition, progeny in the treated group were injected subcutaneously every other day from birth to P28 with an olive oil emulsion containing AY9944; control animals received olive oil emulsion alone. At various postnatal times, tissues from treated and control animals were harvested, and their sterol profiles were analyzed by reversed-phase high-performance liquid chromatography. Companion eyes from animals of both groups were examined histologically at P1. At P28, animals were evaluated by electroretinography; tissues were then harvested for biochemical analysis and companion eyes were subjected to histologic and ultrastructural analyses. RESULTS: Treatment of developing rats with AY9944 caused markedly abnormal accumulation of 7-dehydrosterols and severely reduced cholesterol levels in all tissues examined, relative to control animals. Despite this, treated animals exhibited normal retinal development and had no overt ocular defects or decrease in electroretinographic function, up to P28. CONCLUSIONS: These results were unexpected, given the known biophysical effects of such sterol alterations on membrane properties and the profound dysmorphic and cognitive abnormalities associated with genetic defects in 3beta-hydroxysterol delta7-reductase that have been linked to the SLO syndrome. The results suggest that 7-dehydrosterols can substitute functionally for cholesterol in the retina or perhaps can act synergistically with subthreshold levels of residual cholesterol to allow normal cellular structure and function to be achieved.  (+info)

Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. (5/122)

Opitz syndrome (OS) is a multiple congenital anomaly manifested by abnormal closure of midline structures. The gene responsible for the X-linked form of this disease, MID1, encodes a protein (midin) that contains a RING, two B-boxes, a coiled-coil (the so-called tripartite motif) and an RFP-like domain. The tripartite motif is characteristic of a family of proteins, named the B-box family, involved in cell proliferation and development. Since the subcellular compartmentalization and the ability to form multiprotein structures both appear to be crucial for the function of this family of proteins, we have studied these properties on the wild-type and mutated forms of midin. We found that endogenous midin is associated with microtubules throughout the cell cycle, co-localizing with cytoplasmic fibres in interphase and with the mitotic spindle and midbodies during mitosis and cytokinesis. Immunoprecipitation experiments demonstrated the ability of the tripartite motif to mediate midin homodimerization, consistent with the evidence, obtained by gel filtration analysis, that midin exists in the form of large protein complexes. Functional characterization of altered forms of midin, resulting from mutations found in OS patients, revealed that association with microtubules is compromised, while the ability to homodimerize and form multiprotein complexes is retained. We suggest that midin is involved in the formation of multiprotein structures acting as anchor points to microtubules and that impaired association with these cytoskeletal structures causes OS developmental defects.  (+info)

MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development. (6/122)

The B-box family is an expanding new family of genes encoding proteins involved in diverse cellular functions such as developmental patterning and oncogenesis. A member of this protein family, MID1, is the gene responsible for the X-linked form of Opitz G/BBB syndrome, a developmental disorder characterized by defects of the midline structures. We now report the identification of MID2, a new transcript closely related to MID1. MID2 maps to Xq22 in human and to the syntenic region on the mouse X chromosome. The two X-linked genes share the same domains, the same exon-intron organization, a high degree of similarity at the protein level and the same subcellular localization, both being confined to the cytoplasm in association to micro-tubular structures. The expression pattern studied by RNA in situ hybridization in mouse revealed that Mid2 is expressed early in development and the highest level of expression is detected in the heart, unlike Mid1 for which no expression was detected in the developing heart. Together, these data suggest that midin and MID2 have a similar biochemical function but a different physiological role during development.  (+info)

Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver. (7/122)

The Smith-Lemli-Opitz syndrome (SLOS) is a congenital birth defect syndrome caused by a deficiency of 3beta-hydroxysterol Delta(7)-reductase, the final enzyme in the cholesterol biosynthetic pathway. The patients have reduced plasma and tissue cholesterol concentrations with the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol. Bile acid synthesis is reduced and unnatural cholenoic and cholestenoic acids have been identified in some SLOS patients. To explore the mechanism of the abnormal bile acid production, the activities of key enzymes in classic and alternative bile acid biosynthetic pathways (microsomal cholesterol 7alpha-hydroxylase and mitochondrial sterol 27-hydroxylase) were measured in liver biopsy specimens from two mildly affected SLOS patients. The effects of 7- and 8-dehydrocholesterols on these two enzyme activities were studied by using liver from SLOS model rats that were treated with the Delta(7)-reductase inhibitor (BM15.766) for 4 months and were comparable with more severe SLOS phenotype in plasma and hepatic sterol compositions. In the SLOS patients, cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase were not defective. In BM15.766-treated rats, both enzyme activities were lower than those in control rats and they were competitively inhibited by 7- and 8-dehydrocholesterols. Rat microsomal cholesterol 7alpha-hydroxylase did not transform 7-dehydrocholesterol or 8-dehydrocholesterol into 7alpha-hydroxylated sterols. In contrast, rat mitochondrial sterol 27-hydroxylase catalyzed 27-hydroxylation of 7- and 8-dehydrocholesterols, which were partially converted to 3beta-hydroxycholestadienoic acids. Addition of microsomes to the mitochondrial 27-hydroxylase assay mixture reduced 27-hydroxydehydrocholesterol concentrations, which suggested that 27-hydroxydehydrocholesterols were further metabolized by microsomal enzymes. These results suggest that reduced normal bile acid production is characteristic of severe SLOS phenotype and is caused not only by depletion of hepatic cholesterol but also by competitive inhibition of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase activities by accumulated 7- and 8-dehydrocholesterols. Unnatural bile acids are synthesized mainly by the alternative pathway via mitochondrial sterol 27-hydroxylase in SLOS.  (+info)

Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation. (8/122)

Smith-Lemli-Opitz syndrome, a syndrome of multiple malformations and mental retardation that for years was relegated to the atlases of genetic esoterica, was recently found to be a relatively common inborn error of metabolism. The underlying defect is absent or deficient activity of 7-dehydrocholesterol- delta 7-reductase, the enzyme catalysing the final step of cholesterol synthesis. The discovery of the biochemical defect causing Smith-Lemli-Opitz syndrome has resulted in the development of a diagnostic test and a potentially beneficial treatment (dietary cholesterol supplementation). Infants and young children with the syndrome have shown marked improvement in growth, behaviour and general health after receiving cholesterol therapy; older children and adults have shown some improvement in development and intellectual functioning. Despite the excitement these developments have elicited among geneticists and biochemists, this syndrome remains relatively unknown to many primary care physicians. Increased awareness of Smith-Lemli-Opitz syndrome is needed to identify affected patients so that they and their families can benefit from appropriate treatment and genetic counselling.  (+info)

Microtubule proteins are a class of structural proteins that make up the microtubules, which are key components of the cytoskeleton in eukaryotic cells. The main microtubule protein is tubulin, which exists in two forms: alpha-tubulin and beta-tubulin. These tubulins polymerize to form heterodimers, which then assemble into protofilaments, which in turn aggregate to form hollow microtubules. Microtubules are dynamic structures that undergo continuous assembly and disassembly, and they play crucial roles in various cellular processes, including intracellular transport, cell division, and maintenance of cell shape. Other microtubule-associated proteins (MAPs) also bind to microtubules and regulate their stability, dynamics, and interactions with other cellular structures.

Smith-Lemli-Opitz syndrome (SLOS) is a genetic disorder that affects the development of multiple body systems. It is caused by a deficiency in the enzyme 7-dehydrocholesterol reductase, which is needed for the production of cholesterol in the body.

The symptoms of SLOS can vary widely in severity, but often include developmental delays, intellectual disability, low muscle tone (hypotonia), feeding difficulties, and behavioral problems. Physical abnormalities may also be present, such as cleft palate, heart defects, extra fingers or toes (polydactyly), and genital abnormalities in males.

SLOS is an autosomal recessive disorder, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. It is typically diagnosed through genetic testing and biochemical analysis of blood or body fluids. Treatment for SLOS may include cholesterol supplementation, special education services, and management of associated medical conditions.

Hypertelorism is a medical term that refers to an ocular condition where the distance between two eyes (interpupillary distance) is abnormally increased. It's typically defined as an interpupillary distance that measures more than 2 standard deviations beyond the mean for a given age, gender, and race.

This condition can be associated with various genetic syndromes or conditions such as craniosynostosis (premature fusion of skull sutures), fetal alcohol syndrome, and certain chromosomal abnormalities like Down syndrome. Hypertelorism may also occur in isolation without any other associated anomalies.

It's important to note that hypertelorism can have cosmetic implications, particularly if the distance between the eyes is significantly increased, as it may affect the overall symmetry and appearance of the face. However, in most cases, this condition does not directly impact vision unless there are other related structural abnormalities of the eye or orbit.

Hypospadias is a congenital condition in males where the urethral opening (meatus), which is the end of the urethra through which urine exits, is not located at the tip of the penis but instead appears on the underside of the penis. The severity of hypospadias can vary, with some cases having the meatus located closer to the tip and others further down on the shaft or even at the scrotum or perineum (the area between the scrotum and the anus). This condition affects about 1 in every 200-250 male newborns. The exact cause of hypospadias is not fully understood, but it's believed to be a combination of genetic and environmental factors. Surgical correction is usually recommended during infancy or early childhood to prevent complications such as difficulty urinating while standing, problems with sexual function, and psychological issues related to body image.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Nuclear proteins are a category of proteins that are primarily found in the nucleus of a eukaryotic cell. They play crucial roles in various nuclear functions, such as DNA replication, transcription, repair, and RNA processing. This group includes structural proteins like lamins, which form the nuclear lamina, and regulatory proteins, such as histones and transcription factors, that are involved in gene expression. Nuclear localization signals (NLS) often help target these proteins to the nucleus by interacting with importin proteins during active transport across the nuclear membrane.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). They function by binding to specific DNA sequences, known as response elements, located in the promoter region or enhancer regions of target genes. This binding can either activate or repress the initiation of transcription, depending on the properties and interactions of the particular transcription factor. Transcription factors often act as part of a complex network of regulatory proteins that determine the precise spatiotemporal patterns of gene expression during development, differentiation, and homeostasis in an organism.

Imperforate anus is a congenital condition in which the opening of the anus is absent or abnormally closed or narrowed, preventing the normal passage of stool. This results in a blockage in the digestive tract and can lead to serious health complications if not treated promptly.

The anus is the external opening of the rectum, which is the lower end of the digestive tract. During fetal development, the rectum and anus normally connect through a canal called the anal canal or the recto-anal canal. In imperforate anus, this canal may be completely closed or narrowed, or it may not form properly.

Imperforate anus can occur as an isolated condition or as part of a genetic syndrome or other congenital abnormalities. The exact cause is not fully understood, but it is believed to result from a combination of genetic and environmental factors.

Treatment for imperforate anus typically involves surgery to create an opening in the anus and restore normal bowel function. In some cases, additional procedures may be necessary to correct related abnormalities or complications. The prognosis for individuals with imperforate anus depends on the severity of the condition and any associated abnormalities. With prompt and appropriate treatment, most people with imperforate anus can lead normal lives.

X-linked genetic diseases refer to a group of disorders caused by mutations in genes located on the X chromosome. These conditions primarily affect males since they have only one X chromosome and therefore don't have a second normal copy of the gene to compensate for the mutated one. Females, who have two X chromosomes, are typically less affected because they usually have one normal copy of the gene on their other X chromosome.

Examples of X-linked genetic diseases include Duchenne and Becker muscular dystrophy, hemophilia A and B, color blindness, and fragile X syndrome. Symptoms and severity can vary widely depending on the specific condition and the nature of the genetic mutation involved. Treatment options depend on the particular disease but may include physical therapy, medication, or in some cases, gene therapy.

'Abnormalities, Multiple' is a broad term that refers to the presence of two or more structural or functional anomalies in an individual. These abnormalities can be present at birth (congenital) or can develop later in life (acquired). They can affect various organs and systems of the body and can vary greatly in severity and impact on a person's health and well-being.

Multiple abnormalities can occur due to genetic factors, environmental influences, or a combination of both. Chromosomal abnormalities, gene mutations, exposure to teratogens (substances that cause birth defects), and maternal infections during pregnancy are some of the common causes of multiple congenital abnormalities.

Examples of multiple congenital abnormalities include Down syndrome, Turner syndrome, and VATER/VACTERL association. Acquired multiple abnormalities can result from conditions such as trauma, infection, degenerative diseases, or cancer.

The medical evaluation and management of individuals with multiple abnormalities depend on the specific abnormalities present and their impact on the individual's health and functioning. A multidisciplinary team of healthcare professionals is often involved in the care of these individuals to address their complex needs.

Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is characterized by intellectual and developmental disabilities, distinctive facial features, and sometimes physical growth delays and health problems. The condition affects approximately one in every 700 babies born in the United States.

Individuals with Down syndrome have varying degrees of cognitive impairment, ranging from mild to moderate or severe. They may also have delayed development, including late walking and talking, and may require additional support and education services throughout their lives.

People with Down syndrome are at increased risk for certain health conditions, such as congenital heart defects, respiratory infections, hearing loss, vision problems, gastrointestinal issues, and thyroid disorders. However, many individuals with Down syndrome live healthy and fulfilling lives with appropriate medical care and support.

The condition is named after John Langdon Down, an English physician who first described the syndrome in 1866.

Metabolic syndrome, also known as Syndrome X, is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. It is not a single disease but a group of risk factors that often co-occur. According to the American Heart Association and the National Heart, Lung, and Blood Institute, a person has metabolic syndrome if they have any three of the following five conditions:

1. Abdominal obesity (waist circumference of 40 inches or more in men, and 35 inches or more in women)
2. Triglyceride level of 150 milligrams per deciliter of blood (mg/dL) or greater
3. HDL cholesterol level of less than 40 mg/dL in men or less than 50 mg/dL in women
4. Systolic blood pressure of 130 millimeters of mercury (mmHg) or greater, or diastolic blood pressure of 85 mmHg or greater
5. Fasting glucose level of 100 mg/dL or greater

Metabolic syndrome is thought to be caused by a combination of genetic and lifestyle factors, such as physical inactivity and a diet high in refined carbohydrates and unhealthy fats. Treatment typically involves making lifestyle changes, such as eating a healthy diet, getting regular exercise, and losing weight if necessary. In some cases, medication may also be needed to manage individual components of the syndrome, such as high blood pressure or high cholesterol.

Microtubules are hollow, cylindrical structures composed of tubulin proteins in the cytoskeleton of eukaryotic cells. They play crucial roles in various cellular processes such as maintaining cell shape, intracellular transport, and cell division (mitosis and meiosis). Microtubules are dynamic, undergoing continuous assembly and disassembly, which allows them to rapidly reorganize in response to cellular needs. They also form part of important cellular structures like centrioles, basal bodies, and cilia/flagella.

Nephrotic syndrome is a group of symptoms that indicate kidney damage, specifically damage to the glomeruli—the tiny blood vessel clusters in the kidneys that filter waste and excess fluids from the blood. The main features of nephrotic syndrome are:

1. Proteinuria (excess protein in urine): Large amounts of a protein called albumin leak into the urine due to damaged glomeruli, which can't properly filter proteins. This leads to low levels of albumin in the blood, causing fluid buildup and swelling.
2. Hypoalbuminemia (low blood albumin levels): As albumin leaks into the urine, the concentration of albumin in the blood decreases, leading to hypoalbuminemia. This can cause edema (swelling), particularly in the legs, ankles, and feet.
3. Edema (fluid retention and swelling): With low levels of albumin in the blood, fluids move into the surrounding tissues, causing swelling or puffiness. The swelling is most noticeable around the eyes, face, hands, feet, and abdomen.
4. Hyperlipidemia (high lipid/cholesterol levels): The kidneys play a role in regulating lipid metabolism. Damage to the glomeruli can lead to increased lipid production and high cholesterol levels in the blood.

Nephrotic syndrome can result from various underlying kidney diseases, such as minimal change disease, membranous nephropathy, or focal segmental glomerulosclerosis. Treatment depends on the underlying cause and may include medications to control inflammation, manage high blood pressure, and reduce proteinuria. In some cases, dietary modifications and lifestyle changes are also recommended.

Sjögren's syndrome is a chronic autoimmune disorder in which the body's immune system mistakenly attacks its own moisture-producing glands, particularly the tear and salivary glands. This can lead to symptoms such as dry eyes, dry mouth, and dryness in other areas of the body. In some cases, it may also affect other organs, leading to a variety of complications.

There are two types of Sjögren's syndrome: primary and secondary. Primary Sjögren's syndrome occurs when the condition develops on its own, while secondary Sjögren's syndrome occurs when it develops in conjunction with another autoimmune disease, such as rheumatoid arthritis or lupus.

The exact cause of Sjögren's syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment typically focuses on relieving symptoms and may include artificial tears, saliva substitutes, medications to stimulate saliva production, and immunosuppressive drugs in more severe cases.

Turner Syndrome is a genetic disorder that affects females, caused by complete or partial absence of one X chromosome. The typical karyotype is 45,X0 instead of the normal 46,XX in women. This condition leads to distinctive physical features and medical issues in growth, development, and fertility. Characteristic features include short stature, webbed neck, low-set ears, and swelling of the hands and feet. Other potential symptoms can include heart defects, hearing and vision problems, skeletal abnormalities, kidney issues, and learning disabilities. Not all individuals with Turner Syndrome will have every symptom, but most will require medical interventions and monitoring throughout their lives to address various health concerns associated with the condition.

Myelodysplastic syndromes (MDS) are a group of diverse bone marrow disorders characterized by dysplasia (abnormal development or maturation) of one or more types of blood cells or by ineffective hematopoiesis, resulting in cytopenias (lower than normal levels of one or more types of blood cells). MDS can be classified into various subtypes based on the number and type of cytopenias, the degree of dysplasia, the presence of ring sideroblasts, and cytogenetic abnormalities.

The condition primarily affects older adults, with a median age at diagnosis of around 70 years. MDS can evolve into acute myeloid leukemia (AML) in approximately 30-40% of cases. The pathophysiology of MDS involves genetic mutations and chromosomal abnormalities that lead to impaired differentiation and increased apoptosis of hematopoietic stem and progenitor cells, ultimately resulting in cytopenias and an increased risk of developing AML.

The diagnosis of MDS typically requires a bone marrow aspiration and biopsy, along with cytogenetic and molecular analyses to identify specific genetic mutations and chromosomal abnormalities. Treatment options for MDS depend on the subtype, severity of cytopenias, and individual patient factors. These may include supportive care measures, such as transfusions and growth factor therapy, or more aggressive treatments, such as chemotherapy and stem cell transplantation.

Cushing syndrome is a hormonal disorder that occurs when your body is exposed to high levels of the hormone cortisol for a long time. This can happen due to various reasons such as taking high doses of corticosteroid medications or tumors that produce cortisol or adrenocorticotropic hormone (ACTH).

The symptoms of Cushing syndrome may include:

* Obesity, particularly around the trunk and upper body
* Thinning of the skin, easy bruising, and purple or red stretch marks on the abdomen, thighs, breasts, and arms
* Weakened bones, leading to fractures
* High blood pressure
* High blood sugar
* Mental changes such as depression, anxiety, and irritability
* Increased fatigue and weakness
* Menstrual irregularities in women
* Decreased fertility in men

Cushing syndrome can be diagnosed through various tests, including urine and blood tests to measure cortisol levels, saliva tests, and imaging tests to locate any tumors. Treatment depends on the cause of the condition but may include surgery, radiation therapy, chemotherapy, or adjusting medication dosages.

Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions associated with sudden, reduced blood flow to the heart muscle. This reduction in blood flow, commonly caused by blood clots forming in coronary arteries, can lead to damage or death of the heart muscle and is often characterized by symptoms such as chest pain, shortness of breath, and fatigue.

There are three main types of ACS:

1. Unstable Angina: This occurs when there is reduced blood flow to the heart muscle, causing chest pain or discomfort, but the heart muscle is not damaged. It can be a warning sign for a possible future heart attack.
2. Non-ST Segment Elevation Myocardial Infarction (NSTEMI): This type of heart attack occurs when there is reduced blood flow to the heart muscle, causing damage or death of some of the muscle cells. However, the electrical activity of the heart remains relatively normal.
3. ST Segment Elevation Myocardial Infarction (STEMI): This is a serious and life-threatening type of heart attack that occurs when there is a complete blockage in one or more of the coronary arteries, causing extensive damage to the heart muscle. The electrical activity of the heart is significantly altered, which can lead to dangerous heart rhythms and even cardiac arrest.

Immediate medical attention is required for anyone experiencing symptoms of ACS, as prompt treatment can help prevent further damage to the heart muscle and reduce the risk of complications or death. Treatment options may include medications, lifestyle changes, and procedures such as angioplasty or bypass surgery.

Polycyctic Ovary Syndrome (PCOS) is a complex endocrine-metabolic disorder characterized by the presence of hyperandrogenism (excess male hormones), ovulatory dysfunction, and polycystic ovaries. The Rotterdam criteria are commonly used for diagnosis, which require at least two of the following three features:

1. Oligo- or anovulation (irregular menstrual cycles)
2. Clinical and/or biochemical signs of hyperandrogenism (e.g., hirsutism, acne, or high levels of androgens in the blood)
3. Polycystic ovaries on ultrasound examination (presence of 12 or more follicles measuring 2-9 mm in diameter, or increased ovarian volume >10 mL)

The exact cause of PCOS remains unclear, but it is believed to involve a combination of genetic and environmental factors. Insulin resistance and obesity are common findings in women with PCOS, which can contribute to the development of metabolic complications such as type 2 diabetes, dyslipidemia, and cardiovascular disease.

Management of PCOS typically involves a multidisciplinary approach that includes lifestyle modifications (diet, exercise, weight loss), medications to regulate menstrual cycles and reduce hyperandrogenism (e.g., oral contraceptives, metformin, anti-androgens), and fertility treatments if desired. Regular monitoring of metabolic parameters and long-term follow-up are essential for optimal management and prevention of complications.

Williams Syndrome is a rare genetic disorder caused by the deletion of a small portion of chromosome 7. This results in various developmental and medical problems, which can include:

1. Distinctive facial features such as a broad forehead, wide-set eyes, short nose, and full lips.
2. Cardiovascular disease, particularly narrowed or missing blood vessels near the heart.
3. Developmental delays and learning disabilities, although most people with Williams Syndrome have an IQ in the mild to moderate range of intellectual disability.
4. A unique pattern of strengths and weaknesses in cognitive skills, such as strong language skills but significant difficulty with visual-spatial tasks.
5. Overly friendly or sociable personality, often displaying a lack of fear or wariness around strangers.
6. Increased risk of anxiety and depression.
7. Sensitive hearing and poor depth perception.
8. Short stature in adulthood.

Williams Syndrome affects about 1 in every 10,000 people worldwide, regardless of race or ethnic background. It is not an inherited disorder, but rather a spontaneous genetic mutation.

"Smith-Lemli-Opitz Syndrome". In Pagon, Roberta A; Adam, Margaret P; Bird, Thomas D; Dolan, Cynthia R; Fong, Chin-To; Smith, ... Smith-Lemli-Opitz syndrome is an inborn error of cholesterol synthesis. It is an autosomal recessive, multiple malformation ... Smith, David W.; Lemli, Luc; Opitz, John M. (1964). "A newly recognized syndrome of multiple congenital anomalies". The Journal ... Bukelis, I.; Porter, F. D.; Zimmerman, A. W.; Tierney, E. (2007). "Smith-Lemli-Opitz Syndrome and Autism Spectrum Disorder". ...
A deficiency is associated with Smith-Lemli-Opitz syndrome. All house cats and dogs have higher-than-usual activity of this ... Nowaczyk MJ, Heshka T, Eng B, Feigenbaum AJ, Waye JS (Apr 2001). "DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndrome". ... Nowaczyk MJ, Farrell SA, Sirkin WL, Velsher L, Krakowiak PA, Waye JS, Porter FD (Sep 2001). "Smith-Lemli-Opitz (RHS) syndrome: ... GeneReviews/NIH/NCBI/UW entry on Smith-Lemli-Opitz Syndrome 7-dehydrocholesterol+reductase at the U.S. National Library of ...
Mutations in 7DHCR are linked to Smith-Lemli-Opitz syndrome (SLOS). Mutations in NPC1 have been shown to cause Niemann-Pick ...
"Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome". Human Molecular Genetics. 25 (4): 693- ...
Defective synthesis results in the human inherited disorder lathosterolosis resembling Smith-Lemli-Opitz syndrome. Mice where ... Vitamin D Smith-Lemli-Opitz syndrome 7-Dehydrocholesterol reductase "7-dehydrocholesterol". The American Heritage Stedman's ...
... and biomarker characterization of Smith-Lemli-Opitz syndrome: an update". Journal of Neurodevelopmental Disorders. 8 (1): 12. ... PTEN-associated macrocephaly syndrome, some males with FXS) Syndromes caused by CNVs (e.g.: microdeletion 22q11.2 syndrome) ... Chromosomal (e.g.: Down syndrome) Syndromes caused by mutations in single genes (e.g.: NF1, TSC, ... clinically defined syndrome or from a "genotype first" molecularly defined syndrome.[clarification needed] Following the ...
2018; 35(17). Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome ... 2018; 32(2). Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome. Scientific Reports. 2018; 8(1). ... Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome ... Johns Hopkins University Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an ...
Interruptions in the delivery of cholesterol include Smith-Lemli-Opitz syndrome and abetalipoproteinemia.[verification needed] ... such as in the Triple-A or Allgrove syndrome). DAX-1 mutations may cluster in a syndrome with glycerol kinase deficiency with a ... in Waterhouse-Friderichsen syndrome or antiphospholipid syndrome), particular infections (tuberculosis, histoplasmosis, ... "Autoimmune polyglandular syndrome type 1 , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". ...
A Disorder of Cholesterol Biosynthesis Resembling Smith-Lemli-Opitz Syndrome. JIMD Reports. Cham: Springer International ... Herman GE (April 2003). "Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes". Hum. Mol. Genet. ... October 2002). "Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta- ...
These symptoms resemble those of other defects in cholesterol synthesis such as Smith-Lemli-Opitz syndrome. Scientists have ... 2002). "Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of beta-hydroxysteroid- ...
However a finding such as 2,3-toe syndactyly raises the index of suspicion for Smith-Lemli-Opitz syndrome. Most open source ... Nowaczyk, M. J.; Waye, J. S. (2001). "The Smith-Lemli-Opitz syndrome: A novel metabolic way of understanding developmental ... In some cases, dysmorphic features are part of a larger clinical picture, sometimes known as a sequence, syndrome or ... genetic syndrome or birth defect. Dysmorphology is the study of dysmorphic features, their origins and proper nomenclature. One ...
... a syndrome with features of hydrolethalus and Smith-Lemli-Opitz syndromes. A collaborative multicentre study". Journal of ... which had until then been diagnosed as Smith-Lemli-Opitz syndrome. The doctors discounted several other similar genetic ... that earlier cases were misdiagnosed as other genetic disorders with similar pathology-such as Smith-Lemli-Opitz syndrome-the ... Young-Madders syndrome, alternatively known as Pseudotrisomy 13 syndrome or holoprosencephaly-polydactyly syndrome, is a ...
... syndrome Cartilage-hair hypoplasia Congenital central hypoventilation syndrome MEN2 Mowat-Wilson syndrome Smith-Lemli-Opitz ... "Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease". American ... The disorder may occur by itself or in association with other genetic disorders such as Down syndrome or Waardenburg syndrome. ... syndrome Trisomy 21 (Down syndrome) Some forms of Waardenburg syndrome The disorder may occur by itself or in association with ...
Nowaczyk, MJM; Waye, JS (2001). "The Smith-Lemli-Opitz syndrome: A novel metabolic way of understanding developmental biology, ...
Patau syndrome; Smith-Lemli-Opitz syndrome; Sanfilippo syndrome; 3p deletion syndrome; Chromosome Deletion Dillan 4p Syndrome ( ... Gorlin syndrome (Basal Cell Nevus Syndrome); Cornelia de Lange Syndrome Frontometaphyseal dysplasia; ATRX syndrome; Chromosome ... 9q34 Microdeletion Syndrome or Kleefstra syndrome. 17q12 microduplication syndrome Glabella "confluent eyebrow". ... "Chromosome 3p- syndrome , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". rarediseases.info.nih.gov. ...
... and Glycosylation Disorders and Smith-Lemli-Opitz Syndrome Presenting in the Neonate". Avery's Diseases of the Newborn (Tenth ... As a result, acyl-CoA oxidase deficiency may be misdiagnosed as similar conditions such as Usher syndrome and neonatal ...
Researchers are investigating the genetic similarities between Dubowitz syndrome and Smith-Lemli-Opitz syndrome (SLOS). ... Rare syndromes, Syndromes with craniofacial abnormalities, Genetic disorders with OMIM but no gene, Syndromes affecting head ... Dubowitz syndrome is accompanied by a deficiency in growth hormone. People with Dubowitz syndrome have stunted growth, and ... "Dubowitz syndrome". Encyclopedia of Genetic Disorders. Archived from the original on 2007-04-18. "Dubowitz Syndrome Support ...
Interruptions in the delivery of cholesterol include Smith-Lemli-Opitz syndrome and abetalipoproteinemia.[verification needed] ... These cases may present with symptoms of cortisol excess (see Cushing's syndrome). Sheehan's syndrome: Loss of blood flow to ... such as in the Triple A or Allgrove syndrome). DAX-1 mutations may cluster in a syndrome with glycerol kinase deficiency with a ... in Waterhouse-Friderichsen syndrome or antiphospholipid syndrome), particular infections which can spread to the adrenal cortex ...
A genetic defect in cholesterol synthesis causes Smith-Lemli-Opitz syndrome, which is often associated with low plasma ...
Loss-of-function mutations in the gene encoding 7-DHCR result in Smith-Lemli-Opitz syndrome (SLOS) and dramatic accumulation of ... They have been used to inhibit corticosteroid synthesis in the treatment of Cushing's syndrome and adrenocortical carcinoma, ... Marcello D. Bronstein (1 October 2010). Cushing's Syndrome: Pathophysiology, Diagnosis and Treatment. Springer Science & ... "Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies". Pituitary. 19 (6 ...
... who suffered from developmental disabilities caused by Smith-Lemli-Opitz syndrome. He subsequently remarried to artist ...
Precise examination via ultrasound or at birth is necessary to rule out Meckel syndrome, Trisomy 13, or Smith-Lemli-Opitz ... Hydrolethalus syndrome (HLS) was first mistakenly identified in Finland, during a study on Meckel syndrome. Like HLS, Meckel ... HLS can be distinguished from Meckel syndrome by analysing kidney function, which is dysfunctional in Meckel syndrome as a ... Hydrolethalus syndrome (HLS) is a rare genetic disorder that causes improper fetal development, resulting in birth defects and ...
N syndrome Noonan syndrome Opitz G/BBB syndrome Opitz-Kaveggia syndrome (FGS1) Smith-Lemli-Opitz syndrome (SLOS) Zellweger ... including Smith-Lemli-Opitz syndrome (SLOS), Opitz-Kaveggia syndrome (FGS1), Opitz G/BBB syndrome, Bohring-Opitz syndrome, and ... the Smith-Lemli-Opitz syndrome or of the role of the MID1 gene in early ontogeny following discovery of the Opitz GBBB syndrome ... Bohring-Opitz syndrome C syndrome Cornelia de Lange syndrome KBG syndrome Brancati, F; Sarkozy, A; Dallapiccola, B (2006). "KBG ...
Cystic fibrosis Smith-Lemli-Opitz syndrome Familial dysautonomia Epidermolysis Bullosa simplex Pfeiffer syndrome Autoimmune ... polyendocrine syndrome type 1 (APECED) Acampomelic campomelic dysplasia Atelosteogenesis DNA sequences from 589,306 people were ...
Turner's syndrome (XO), Jacobsen syndrome (11q deletion syndrome), Holt-Oram syndrome, and Smith-Lemli-Opitz syndrome. A ... HLHS is also associated with several genetic syndromes, including trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), ... Wikimedia Commons has media related to Hypoplastic left heart syndrome. Hypoplastic left heart syndrome Archived 2013-03-14 at ... Hypoplastic left heart syndrome (HLHS) is a rare congenital heart defect in which the left side of the heart is severely ...
... and discovered and delineated Smith-Lemli-Opitz syndrome, Opitz-Kaveggia syndrome, Opitz G/BBB syndrome, Bohring-Opitz syndrome ... first baseman Alex Smith - Washington Redskins quarterback, first overall pick in the 2005 NFL Draft Dave Smith - former NFL ... Joseph Fielding Smith - Presiding Patriarch of the LDS Church (1943-1946) George Albert Smith - President of the LDS Church ( ... Mormon philosopher Darron Smith Steven C. Wheelwright - President of Brigham Young University-Hawaii (2007-) O. Meredith Wilson ...
Smith-Lemli-Opitz syndrome MeSH C16.131.077.938 - Waardenburg syndrome MeSH C16.131.077.951 - Wolfram syndrome MeSH C16.131. ... Zellweger syndrome MeSH C16.320.565.556.850 - Smith-Lemli-Opitz syndrome MeSH C16.320.565.556.925 - xanthomatosis, ... Smith-Lemli-Opitz syndrome MeSH C16.320.577.074 - distal myopathies MeSH C16.320.577.149 - glycogen storage disease type VII ... MeSH C16.131.077.065 - Alagille syndrome MeSH C16.131.077.095 - Angelman syndrome MeSH C16.131.077.112 - Bardet-Biedl syndrome ...
... who has developmental disabilities caused by Smith-Lemli-Opitz syndrome. The film received a Canadian Screen Award nomination ...
Prader-Willi syndrome 50%, Werdnig-Hoffman syndrome 10% Smith-Lemli-Opitz syndrome 40% Fetal alcohol syndrome 40% Potter ... 13 trisomy syndrome 12% 18 trisomy syndrome 43% 21 trisomy syndrome 5% de Lange syndrome 10% Anencephalus 6-18%, Spina bifida ... Braun FH, Jones KL, Smith DW (1975). "Breech presentation as an indicator of fetal abnormality". J Pediatr. 86 (3): 419-21. doi ... Congenital bilateral perisilvian syndrome 33.3 Symmetric fetal growth restriction 40% Asymmetric fetal growth restriction 40% ...
Mycosis fungoides Smith-Lemli-Opitz syndrome Porphyria cutanea tarda Also, many conditions are aggravated by strong light, ... lupus erythematosus Sjögren syndrome Sinear-Usher syndrome Rosacea Dermatomyositis Darier's disease Kindler-Weary syndrome The ... Conditions that may include sensitivity to light include vertigo and chronic fatigue syndrome. Controlled application of ... Psoriasis Atopic eczema Mastocytosis Mast cell activation syndrome Histamine intolerance Erythema multiforme Seborrhoeic ...
Smith also co-discovered Smith-Lemli-Opitz syndrome, Marshall-Smith syndrome and Ruvalcaba-Myhre-Smith syndrome, Smith-Theiler- ... The condition known as Aase-Smith syndrome is named for Smith and colleague Jon Morton Aase. ... American Journal of Pediatics Obituary David Weyhe Smith, Who Named It? Graham, John M.; Smith, David W.. Smith's recognizable ... Jones K.L.; Smith D. W. (1973). "Recognition of the fetal alcohol syndrome in early infancy". Lancet. 2 (7836): 999-1001. doi: ...
"Smith-Lemli-Opitz Syndrome". In Pagon, Roberta A; Adam, Margaret P; Bird, Thomas D; Dolan, Cynthia R; Fong, Chin-To; Smith, ... Smith-Lemli-Opitz syndrome is an inborn error of cholesterol synthesis. It is an autosomal recessive, multiple malformation ... Smith, David W.; Lemli, Luc; Opitz, John M. (1964). "A newly recognized syndrome of multiple congenital anomalies". The Journal ... Bukelis, I.; Porter, F. D.; Zimmerman, A. W.; Tierney, E. (2007). "Smith-Lemli-Opitz Syndrome and Autism Spectrum Disorder". ...
... syndrome caused by a defect in cholesterol synthesis. Smith-Lemli-Opitz syndrome is an autosomal recessive genetic condition ... Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital anomalies (MCA)/mental retardation (MR) ... Smith-Lemli-Opitz syndrome appears to be uncommon in Japan. The frequency of Smith-Lemli-Opitz syndrome appears to be similar ... encoded search term (Smith-Lemli-Opitz Syndrome) and Smith-Lemli-Opitz Syndrome What to Read Next on Medscape ...
We have reviewed all known UK cases of Smith-Lemli-Opitz syndrome. Among 49 cases with proven 7-dehydrocholesterol reductase ...
Smith-Lemli-Opitz syndrome (SLOS) or RSH syndrome comprises multiple congenital anomalies and mental retardation. The ... Smith-Lemli-Opitz syndrome (SLOS) or RSH syndrome comprises multiple congenital anomalies and mental retardation. The ... Porter FD (2000) RSH/Smith-Lemli-Opitz syndrome: A multiple congenital anomaly/mental retardation syndrome due to an inborn ... Yu H, Tint GS, Salen G and Patel SB (2000) Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR- ...
Smith-Lemli-Opitz Syndrome, Type II*Smith-Lemli-Opitz Syndrome, Type II ... Smith-Lemli-Opitz Syndrome, Type I*Smith-Lemli-Opitz Syndrome, Type I ... "Smith-Lemli-Opitz Syndrome" by people in this website by year, and whether "Smith-Lemli-Opitz Syndrome" was a major or minor ... Smith-Lemli-Opitz Syndrome*Smith-Lemli-Opitz Syndrome. *Smith Lemli Opitz Syndrome ...
PURPOSE: Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive syndrome characterized by congenital anomalies affecting ... Although the syndrome raises a number of potential anesthetic concerns, few complications were seen. This is consistent with ... Smith-Lemli-Opitz Syndrome (MeSH) published in * Canadian Journal of Anaesthesia Journal ...
Clinical Molecular Genetics test for Smith-Lemli-Opitz syndrome and using Sequence analysis of the entire coding region, Bi- ... Smith-Lemli-Opitz Syndrome. *GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is ... for Smith-Lemli-Opitz syndrome. Offered by Asper Biogene ...
Smith-Lemli-Opitz syndrome. Lysosomal storage disorders. Gaucher disease. Fabry disease. Hurler syndrome ...
Smith-Lemli-Opitz Syndrome. *. Vitamin D metabolism gene polymorphisms may play role in in Smith-Lemli-Opitz syndrome ... Treatment Options for Smith-Lemli-Opitz Syndrome. *. Study finds link between maternal PCOS and aneuploidy screening outcomes ... Vitamin D metabolism gene polymorphisms may play role in in Smith-Lemli-Opitz syndrome. The role of vitamin D metabolism gene ... Home Vitamin D metabolism gene polymorphisms may play role in in Smith-Lemli-Opitz syndrome ...
Laurence-Moon-Biedl syndrome. *Rubinstein-Taybi syndrome. *Smith-Lemli-Opitz syndrome. *Trisomy 13 ...
Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J (1999). Adrenal insufficiency in Smith-Lemli-Opitz syndrome. ... such as the Smith-Lemli-Opitz syndrome, Alzheimers, and Niemann-Pick type C diseases (Dietschy and Turley, 2004; Pfrieger, ... Taylor AE, Guthrie PA, Smith GD, Golding J, Sattar N, Hingorani AD et al (2011). IQ, educational attainment, memory and plasma ... release and to the appearance of neurodegenerative and psychological disorders in rodents such as depressive-like syndromes ( ...
RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be associated with a ... N2 - RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be associated ... AB - RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be associated ... abstract = "RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be ...
A Smith Lemli Opitz syndrome patient diagnosed with mild symptoms Hafif klinik belirtilerle tani alan bir Smith Lemli Opitz ... Smith Lemli Opitz Syndrome (SLOS) is an autosomal recessive cholesterol biosynthesis defect which is characterized by both ... Keywords: Mental retardation, Microcephaly, Smith-Lemli-Opitz syndrome * Lokman Hekim University Affiliated: Yes ...
Smith-Lemli-Opitz Syndrome. Angelman Syndrome. Asthma. Bipolar. Cardiovascular. Developmental Delay. Learning Disability. Spina ... Down Syndrome. Mental Health Condition. Spinal Cord Injury. Depression. ADHD. Anxiety. Autism Spectrum Disorder. Deaf or Hard ...
Smith-Lemli-Opitz syndrome.. What have other people written in the IEP to address the sensory defensiveness in particular? ...
Smith-Lemli-Opitz syndrome. DHCR7. CNV. Retinitis pigmentosa 59. DHDDS. CNV. Dyskeratosis congenita, X-linked. DKC1. CNV. ... Gitelman syndrome. SLC12A3. CNV. Agenesis of the corpus callosum with peripheral neuropathy (Andermann syndrome). SLC12A6. CNV ... Congenital myasthenic syndrome, RAPSN-related. RAPSN. CNV. Pontocerebellar hypoplasia, type 1 and 6, RARS2-related. RARS2. CNV ... Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria). SUCLA2. CNV. ...
Abstract: Smith Lemli Opitz Syndrome (SLOS) is a complex genetic disorder caused by a metabolic error in cholesterol metabolism ... Assessment and Treatment of Aberrant Behaviors in Children with Smith-Lemli-Opitz Syndrome. ... the assessment and treatment of self-injury and other problem behaviors in a group of children with Smith-Lemli-Opitz syndrome. ... Abstract: Cornelia de Lange syndrome (CdL) is a congenital syndrome that affects 1:10,000 to 1:30,000 live births. Children ...
Smith-Lemli-Opitz Syndrome (SLOS) (PathBank: SMP0000389). *CHILD Syndrome (PathBank: SMP0000387). *Desmosterolosis (PathBank: ... Leigh Syndrome (PathBank: SMP0000196). *Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) (PathBank: SMP0000334 ...
Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/ß-catenin defects in ... Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet. 2012 Nov 15; 160C(4 ...
Selective antibody immune deficiency in a patient with Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2005; 28 (2):181-6 View ... Haralambieva IH, Oberg AL, Ovsyannikova IG, Kennedy RB, Grill DE, Middha S, Bot BM, Wang VW, Smith DI, Jacobson RM, Poland GA. ... Juhn YJ, Kita H, Lee LA, Smith RW, Bagniewski SM, Weaver AL, Pankratz VS, Jacobson RM, Poland GA. Childhood asthma and human ... Juhn YJ, Kita H, Lee LA, Swanson RJ, Smith R, Bagniewski SM, Weaver AL, Pankratz VS, Jacobson RM, Poland GA. Childhood asthma ...
OMIM (Online Mendelian Inheritance in Man) søkeord: Smith-Lemli-Opitz syndrome. Vil du dele dette med noen andre? ...
He described, for instance, the first known case of the Smith-Lemli-Opitz syndrome. Individuals who suffer from this syndrome ... The external characteristics of the syndrome are diverse and range from female genitalia in combination with a male chromosome ...
Differential diagnoses include trisomy 13, Bardet-Biedl syndrome, Hydrolethalus, and Smith-Lemli-Opitz Syndrome. ... Fetuses affected by Meckel syndrome (MKS) survive only a few days to a few weeks at the most, or die in utero. The main CNS ... Meckel syndrome. Disease definition A rare, lethal, genetic, multiple congenital anomaly disorder characterized by the triad of ... Most of these genes are also responsible for Joubert syndrome, leading to the concept that MKS is the extreme lethal phenotype ...
Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/?-catenin defects in ... S Grosswendt, H Kretzmer, ZD Smith, AS Kumar, S Hetzel, L Wittler, S Klages, B Timmermann, S Mukherji, A Meissner Epigenetic ... T Wang, P Nimkingrat, CA Smith, A Cheng, TE Hardingham, SJ Kimber Enhanced chondrogenesis from human embryonic stem cells Stem ... WY Chan WRN promotes bone development and growth by unwinding SHOX-G-quadruplexes via its helicase activity in Werner Syndrome ...
Fluids Investigated for the Determination of Cholesterol and 7-Dehydrocholesterol for Suspected Smith-Lemli-Opitz Syndrome ( ... Acute Dehydration in Nephrotic Syndrome: A Case Report (Articles) Gianluigi Ardissino, Andrée Van Lierde, Gabriella Moroni, ...
Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-GC is found in over sixty ... Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz Syndrome. Journal of ... Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz syndrome. Journal of ... Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse. Molecular genetics and ...
Other genetic or metabolic disorders and syndromes (Ehlers-Danlos syndrome, mitochondrial myopathies, Smith-Lemli-Opitz ... Ehlers-Danlos syndrome care. The Special Care Clinic is home to a multidisciplinary team that focuses on providing care to ... Chromosomal abnormalities (Down syndrome and other chromosomal rearrangements). * ... we can provide a highly individualized approach to the relief of symptoms caused by Ehlers-Danlos syndrome to help your child ...
I did the Disney Marathon this year and raised money for my BFFs baby, who has Smith-Lemli-Opitz Syndrome. I didnt go through ...
She has investigated disorders like Smith-Lemli-Opitz syndrome, Niemann-Pick disease, and other genetic brain diseases. She now ... Csoka was instrumental in the identification of the gene that causes Hutchinson-Gilford Progeria Syndrome (progeria), a disease ... which produces a Parkinsonian-like syndrome when injected into certain laboratory animals. Using this selective neurotoxin, we ...
  • Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital anomaly (MCA)/ intellectual disability (ID) syndrome caused by a defect in cholesterol synthesis. (medscape.com)
  • Smith-Lemli-Opitz syndrome (SLOS) or RSH syndrome comprises multiple congenital anomalies and mental retardation. (scielo.br)
  • Smith-Lemli-Opitz (SLOS) or RSH syndrome (MIM 270400) comprises multiple congenital anomalies, mental retardation and an autosomal recessive inborn error of cholesterol metabolism. (scielo.br)
  • PURPOSE: Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive syndrome characterized by congenital anomalies affecting the airway, cardiorespiratory, gastrointestinal, genitourinary, and central nervous systems. (mcmaster.ca)
  • Smith Lemli Opitz Syndrome (SLOS) is an autosomal recessive cholesterol biosynthesis defect which is characterized by both multiple kongenital anomaly and mental retardation. (lokmanhekim.edu.tr)
  • Through medical conferences, doctors referred Aryanna to the National Institutes of Health (NIH) to determine if Aryanna might have a rare metabolic disorder called Smith-Lemli-Opitz Syndrome (SLOS). (childrensinn.org)
  • Smith-Lemli-Opitz syndrome (SLOS) is a rare variable genetic disorder that is characterized by slow growth before and after birth, small head (microcephaly), mild to moderate intellectual disability and multiple birth defects. (vumc.org)
  • According to several medical resources, Smith-Lemli-Opitz Syndrome (SLOS) is congenital and caused by mutation, e.g. (stackexchange.com)
  • In the case of Smith-Lemli-Opitz syndrome, the precursor 7DHC is potentially toxic in high concentrations, and cholesterol deficiency is almost certainly detrimental. (medscape.com)
  • [ 6 ] A deficiency of the microsomal enzyme DHCR7, which reduces the 7-8 double bond of 7DHC to form cholesterol in the final step of the cholesterol synthetic pathway, was hypothesized and later proven to cause Smith-Lemli-Opitz syndrome. (medscape.com)
  • This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY. (rush.edu)
  • RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be associated with a severe deficiency of cholesterol biosynthesis and markedly elevated plasma and tissue levels of 7-dehydrocholesterol (7DHC), the immediate precursor of cholesterol in the Kandutsch-Russell biosynthetic pathway. (johnshopkins.edu)
  • Smith-Lemli-Opitz syndrome is usually suspected clinically, but the diagnosis must be confirmed by biochemical and/or molecular genetic studies. (medscape.com)
  • Postnatally, the syndrome is usually suspected clinically, but biochemical and/or genetic testing is necessary for diagnosis. (medscape.com)
  • Measurement of plasma sterols, including, at a minimum, cholesterol and 7DHC, is the biochemical test for Smith-Lemli-Opitz syndrome. (medscape.com)
  • Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. (bmj.com)
  • [ 5 ] The clinical characteristics of Smith-Lemli-Opitz syndrome have been well established over the past 4 decades. (medscape.com)
  • As demonstrated in other clinical syndromes when redefined biochemically, we have found a wider range of clinical expression of RSH/SLO than previously recognized. (johnshopkins.edu)
  • 1%) of individuals with clinical findings of the 22q11.2 deletion syndrome have chromosomal rearrangements involving 22q11.2, such as a translocation between chromosome 22 and another chromosome. (22q.org)
  • Clinical and genetic analysis of a Chinese pedigree affected with Smith-Lemli-Opitz syndrome]. (nih.gov)
  • Smith-Lemli-Opitz syndrome, cholesterol metabolism, 7-dehydrocholesterol. (scielo.br)
  • The role of vitamin D metabolism gene polymorphisms (vitDMGPs) in various health conditions, including Smith-Lemli-Opitz syndrome, is critical, according to a comprehensive bibliometric study. (medjournal360.com)
  • Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. (harvard.edu)
  • Most of these genes are also responsible for Joubert syndrome, leading to the concept that MKS is the extreme lethal phenotype of Joubert syndrome. (orpha.net)
  • We report here the identification of mutations in sterol-C4-methyl oxidase-like gene (SC4MOL) as the cause of an autosomal recessive syndrome in a human patient with psoriasiform dermatitis, arthralgias, congenital cataracts, microcephaly, and developmental delay. (jci.org)
  • D. W. Smith, L. Lemli and J. M. Opitz, "A Newly Recognized Syndrome of Multiple Congenital Anomalies," The Journal of Pediatrics, Vol. 64, 1964, pp. 210-217. (scirp.org)
  • It is an autosomal recessive, multiple malformation syndrome caused by a mutation in the enzyme 7-Dehydrocholesterol reductase encoded by the DHCR7 gene. (wikipedia.org)
  • As a postdoctoral research associate at Brown University, Dr. Csoka was instrumental in the identification of the gene that causes Hutchinson-Gilford Progeria Syndrome (progeria), a disease with many features of "accelerated aging. (howard.edu)
  • These individuals may have a change in a gene within the regions, such as TBX1, or a different condition such as CHARGE syndrome. (22q.org)
  • Smith-Lemli-Opitz syndrome is an inborn error of cholesterol synthesis. (wikipedia.org)
  • Differential diagnoses include trisomy 13, Bardet-Biedl syndrome, Hydrolethalus, and Smith-Lemli-Opitz Syndrome. (orpha.net)
  • Smith, Lemli, and Opitz initially described Smith-Lemli-Opitz syndrome (while working at the University of Wisconsin) as a genetic MCA/ID syndrome, in 1964. (medscape.com)
  • His work in that section has focused on understanding two rare genetic disorders involving cholesterol, Smith-Lemli-Opitz syndrome and Niemann-Pick disease type C. Smith-Lemli-Opitz syndrome results from a defect in the ability to manufacture cholesterol. (nih.gov)
  • Defects in cholesterol synthesis result in a wide variety of symptoms, from neonatal lethality to the relatively mild dysmorphic features and developmental delay found in individuals with Smith-Lemli-Opitz syndrome. (jci.org)
  • CHARGE is a congenital disorder and an acronym for the constellation of medical problems that define this syndrome: coloboma of the eye, heart defects, atresia of the choanae, retardation of growth or development, genital hypoplasia, and ear malformation. (abainternational.org)
  • Smith-Lemli-Opitz Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (rush.edu)
  • Fetal ultrasonography may reveal anomalies suggestive of Smith-Lemli-Opitz syndrome. (medscape.com)
  • The etiology of Smith-Lemli-Opitz syndrome was unknown until 1993, when Irons et al discovered that patients with Smith-Lemli-Opitz syndrome had low plasma cholesterol levels and accumulated sterol precursors such as 7DHC. (medscape.com)
  • The number of children diagnosed with CHARGE Syndrome is increasing, and several studies have reported that children with CHARGE syndrome exhibit multiple behavioral problems (e.g., repetitive behaviors, non-compliance, and social skills deficits) and educational problems. (abainternational.org)
  • A few individuals with findings of the 22q11.2 deletion syndrome have normal routine cytogenetic studies and no deletion by FISH, MLPA, CGH or microarray. (22q.org)
  • Currently, no treatment has proven effective long-term for patients with the syndrome. (medscape.com)
  • As mentioned, no treatment has so far proven effective long-term for patients with Smith-Lemli-Opitz syndrome. (medscape.com)
  • Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/ß-catenin defects in neuronal cholesterol synthesis phenotypes. (harvard.edu)
  • The Special Care Clinic is home to a multidisciplinary team that focuses on providing care to patients with Ehlers-Danlos syndrome (EDS) . (childrenscolorado.org)
  • The third presenter will describe the treatment of severe aggression associated with Cornelia de Lange syndrome. (abainternational.org)
  • The most severely affected individuals (those with the condition formerly referred to as Smith-Lemli-Opitz syndrome type II) have multiple congenital malformations and are often miscarried or stillborn or die in the first weeks of life. (medscape.com)
  • Large polycystic kidneys with cystic dysplasia are a constant feature of Meckel syndrome. (orpha.net)
  • This graph shows the total number of publications written about "Smith-Lemli-Opitz Syndrome" by people in this website by year, and whether "Smith-Lemli-Opitz Syndrome" was a major or minor topic of these publications. (rush.edu)
  • Below are the most recent publications written about "Smith-Lemli-Opitz Syndrome" by people in Profiles. (rush.edu)
  • Another reason for children having an upturned nose, based on a medical condition is the Kaufman oculocerebrofacial syndrome which affects their facial features, mental retardation, and eye abnormalities amongst other aspects. (simplyaesthetic.co.uk)
  • Child with Smith-Lemli-Opitz syndrome. (medscape.com)
  • The next presenter will describe the treatment of severe problem behavior in a child with CHARGE syndrome. (abainternational.org)
  • No treatment is currently available for Meckel syndrome which has a constantly fatal outcome. (orpha.net)
  • a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. (nih.gov)
  • In this study, principles of applied behavior analysis (ABA) were used to decrease self-injurious and disruptive behaviors for a 5-year old boy with CHARGE syndrome. (abainternational.org)
  • The final presentation will summarize the assessment and treatment of self-injury and other problem behaviors in a group of children with Smith-Lemli-Opitz syndrome. (abainternational.org)